ACIU - acimmune.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Ushbu grafikdagi tasdiqlangan narxlar tarixi FDA ning qat'iy nazorati va ulkan R&D xarajatlarining ta'sirini baholash imkonini beradi, bunda ko'rsatkich 0.09 miqdorida turibdi. AC Immune o'z biznesini demensiyaga qarshi innovatsion dori vositalarini yaratishga yo'naltirgan, bu esa uni bozor tebranishlariga chidamli qiladi. Kompaniya neyrodegenerativ patologiyalarni davolashga bo'lgan jiddiy ijtimoiy ehtiyojdan foydalanib, terapevtik yechimlar portfelini faol ravishda kengtirmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ACIU_-_AC-Immune_-_Long-Term-Debt-to-Equity-Ratio "ACIU: AC Immune SA Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
AC Immune (ACIU) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati AC Immune|ACIU - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati acimmune.com|ACIU - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati AC Immune SA|ACIU - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari AC Immune
Kompaniyaning umumiy tahlili:ACIU AC Immune S.A.
Ushbu ko'rsatkich kompaniyaning tashqi uzoq muddatli moliyalashtirishga bog'liqlik darajasini aniqlash uchun bir yildan ortiq muddatga ega majburiyatlarni umumiy kapital bilan solishtiradi. Kapitalga nisbatan uzoq muddatli qarz tuzilmasini tahlil qilish orqali investor AC Immune (ACIU) o'zining neyrodegeneratsiya tadqiqotlarini qanchalik darajada ichki resurslar hisobidan moliyalashtirishini baholashi mumkin, bu esa strategik sherikliklarga kirishda emitentning moliyaviy barqarorligini tasdiqlaydi.
Raqobatchilar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning kapitalga nisbati BHVN (Biohaven)|Uzoq muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals Inc AMLX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma|Uzoq muddatli qarzning kapitalga koeffitsiyenti Praxis Corp PRAX|Uzoq muddatli qarzning kapitalga nisbati AVXL (Anavex Life Sciences)|CBLL: Uzoq muddatli qarzdorlikning kapitalga nisbati|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp. (OMER)|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati VYGR (voyagertherapeutics.com)|NMRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Scilex Holding SCLX|TVGN (Tevogen Bio Holdings, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|ACOG - Uzoq muddatli majburiyatlarning kapitalga nisbati|CGTX: Uzoq muddatli qarzning kapitalga nisbati|inhibikase.com (IKT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Therapeutics|COYA (Coya Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati vistagen.com VTGN|Uzoq muddatli qarzning o'z kapitaliga nisbati OVID (Ovid Therapeutics)|acumenpharm.com - Uzoq muddatli qarzning kapitalga nisbati|CervoMed (CRVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CLNN|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|Annovis Bio (ANVS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti GRCE (gracetx.com)|AIFF: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ANEW Medical KLTO|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|RVPH - Uzoq muddatli qarzning kapitalga nisbati|MTVA (metaviatx.com) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis Inc.|HSDT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Passage Bio Corp|NEUP (Neuphoria Therapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NERV (minervaneurosciences.com)|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Addex Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Cyclerion Therapeutics (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc (CRGT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Avenue Therapeutics Inc.|Brainstorm Cell Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI: Uzoq muddatli qarzning kapitalga nisbati|LBPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Marinus - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NKGen Biotech Corp|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix SNPX|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Trevena Inc. (TRVN)|VIGL: Uzoq muddatli qarzning kapitalga nisbati|WENA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati